Investors cheered the European Central Bank’s decision to hold interest rates steady at historic lows. The Dow zoomed 320 points to 17,489. Nasdaq jumped 79 points to 4,920.

On the upside

Trinity Biotech (Nasdaq: TRIB) reported higher third quarter earnings.

Boise Cascade (NYSE: BCC) reported third quarter earnings and revenue that beat expectations.

Credit Suisse upgraded Energy Recovery (Nasdaq: ERII) from a Neutral rating to an Outperform rating.

On the downside

The Food and Drug Administration warned that patients using AbbVie’s (NYSE: ABBV) hepatitis C treatments Viekira Pak and Technivie are at a higher risk of serious liver injury.

Shares of Encanta Pharmaceuticals (Nasdaq: ENTA), which helped develop some of AbbVie’s treatments, plunged on the FDA warning.

Cabela (NYSE: CAB) disappointed with lower third quarter earnings that fell short of expectations.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 surged 33 points to 2,052. Bitcoin added $5 to $270.